Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
1.460
0.00 (0.00%)
At close: Mar 12, 2025, 4:00 PM
1.452
-0.008 (-0.56%)
After-hours: Mar 12, 2025, 5:08 PM EST
Femasys Employees
As of December 31, 2023, Femasys had 34 total employees, including 32 full-time and 2 part-time employees. The number of employees decreased by 2 or -5.56% compared to the previous year.
Employees
34
Change (1Y)
-2
Growth (1Y)
-5.56%
Revenue / Employee
$37,078
Profits / Employee
-$532,453
Market Cap
33.43M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 34 | -2 | -5.56% |
Dec 31, 2022 | 36 | 7 | 24.14% |
Dec 31, 2021 | 29 | 3 | 11.54% |
Dec 31, 2020 | 26 | 0 | - |
Dec 31, 2019 | 26 | - | - |
FEMY News
- 15 days ago - Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials - GlobeNewsWire
- 4 weeks ago - Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices - GlobeNewsWire
- 5 weeks ago - Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control - GlobeNewsWire
- 7 weeks ago - Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment - GlobeNewsWire
- 3 months ago - Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment - GlobeNewsWire
- 4 months ago - Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control - GlobeNewsWire
- 5 months ago - Femasys to Exhibit at ASRM 2024 and Participate in the Congress' KEEPR Education Program - GlobeNewsWire